Lumida
/ATLN
⌘K
ATLN

ATLN

ATLN
$0.90USD-2.16%-0.02 today

MARKET CAP

73.2M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$0
$5

AI Summary

Stalk
TrimMedium

ATLN remains in a Stage 4 decline with clear LH/LL structure under declining EMAs and DMAs. The recent rally off the June washout has extended into resistance without clear exhaustion or reversal. With no mean-reversion eligibility and price still below major moving averages, medium-term bias is bearish. Execution should be deferred until price rejects near prior swing highs or the 50 DMA.

  • Revenue jumped 176.9% YoY to $569.7M in H1 2026, with Q2 at $319.8M (210.8% YoY).
  • SG&A expenses dropped to 11.75% of revenue from 18.3%, boosting operating leverage.
  • Q2 net loss of $86.4M and H1 loss of $117.1M indicate financial strain.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Atlantic International Corp., operating as Circle8 Group (Nasdaq: CIRC), is an emerging leader in the technology and services sector, primarily known for its wide range of international operations including digital analytics and software development. The company has seen significant growth partly due to its expansion strategy, which involves strategic acquisitions, such as the recent purchase of Circle8 Group B.V. This positions Circle8 within the digital transformation theme, catering to businesses that are increasingly relying on data analytics and technology to enhance performance.

Bull says

  • Revenue jumped 176.9% YoY to $569.7M in H1 2026, with Q2 at $319.8M (210.8% YoY).
  • SG&A expenses dropped to 11.75% of revenue from 18.3%, boosting operating leverage.
  • Circle8 Group B.V. deal added $206M to Q2 sales, expanding international reach.
  • Cash and equivalents rose to $19.3M from $0.1M, strengthening liquidity for growth.
  • High earnings yield and positive momentum factors suggest undervaluation and upward price drivers.
  • Secular digital transformation demand underpins analytics and cloud service growth.

Bear says

  • Q2 net loss of $86.4M and H1 loss of $117.1M indicate financial strain.
  • Delayed 10-Q filing risks regulatory scrutiny and could erode investor confidence.
  • $60.4M litigation settlement charge weighed on margins and may recur.
  • Reliant on sustained high market demand; any slowdown could slash revenues.
  • Low profitability factors and elevated leverage risk raise financial health concerns.
  • High short-interest suggests negative investor sentiment and potential volatility.